Mechanistically, we identified that METTL3 promotes tumor migration and tumor spheroid formation (stem-cell-like tumorigenic cells), and ABCD1 is an m6A target of METTL3 to treat or prevent kidney cancer metastases. Here, METTL3 is linked to neoplasm.